Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs

Gianni Sava, Gérard Jaouen, Elizabeth A. Hillard, Alberta Bergamo
  • Dalton Transactions, January 2012, Royal Society of Chemistry
  • DOI: 10.1039/c2dt30075c
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: